Jeff Ajer
2018
Compensation breakdown
| Non-Equity Incentive Plan | $450,240 |
|---|---|
| Option Awards | $1,373,198 |
| Salary | $554,232 |
| Stock Awards | $2,146,078 |
| Other | $21,635 |
| Total | $4,545,383 |
Ajer received $2.1M in stock awards, accounting for 47% of the total pay in 2018.
Ajer also received $450.2K in non-equity incentive plan, $1.4M in option awards, $554.2K in salary and $21.6K in other compensation.
Rankings
In 2018, Jeff Ajer's compensation ranked 2,314th out of 14,244 executives tracked by ExecPay. In other words, Ajer earned more than 83.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,314 out of 14,244 | 84th |
Division Manufacturing | 845 out of 5,758 | 85th |
Major group Chemicals And Allied Products | 283 out of 2,119 | 87th |
Industry group Drugs | 228 out of 1,808 | 87th |
Industry Pharmaceutical Preparations | 177 out of 1,382 | 87th |
Pay ratio
| Jeff Ajer's Pay | $4,545,383 |
|---|---|
| Median Employee's Pay | $160,698 |
| Pay Ratio | 28to 1 |
In 2018, the annual total compensation of Jeff Ajer was $4,545,383.
The annual total compensation of the median employee at BioMarin Pharmaceutical was $160,698.
The ratio of Jeff Ajer's pay to the pay of median employee was therefore 28 to one.
Ajer's colleagues
We found five more compensation records of executives who worked with Jeff Ajer at BioMarin Pharmaceutical in 2018.
2018
Jean-Jacques Bienaim
BioMarin Pharmaceutical
Chief Executive Officer
2018
Henry Fuchs
BioMarin Pharmaceutical
President, Worldwide R&D
2018
Daniel Spiegelman
BioMarin Pharmaceutical
Chief Financial Officer
2018
Robert Baffi
BioMarin Pharmaceutical
Executive Vice President, Technical Operations
2018
Brian Mueller
BioMarin Pharmaceutical
Chief Financial Officer
News
April 12, 2022
April 13, 2021
April 14, 2020
April 23, 2019